Fennec Pharmaceuticals Statistics
Total Valuation
FENC has a market cap or net worth of $361.89 million. The enterprise value is $320.64 million.
| Market Cap | 361.89M |
| Enterprise Value | 320.64M |
Important Dates
The last earnings date was Tuesday, August 11, 2026, before market open.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FENC has 35.07 million shares outstanding. The number of shares has increased by 16.69% in one year.
| Current Share Class | 35.07M |
| Shares Outstanding | 35.07M |
| Shares Change (YoY) | +16.69% |
| Shares Change (QoQ) | +2.48% |
| Owned by Insiders (%) | 2.91% |
| Owned by Institutions (%) | 25.32% |
| Float | 19.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 17.39 |
| PS Ratio | 6.35 |
| Forward PS | 4.36 |
| PB Ratio | 8.85 |
| P/TBV Ratio | 8.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.85
| Current Ratio | 5.85 |
| Quick Ratio | 5.21 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.19 |
Financial Efficiency
Return on equity (ROE) is -18.58% and return on invested capital (ROIC) is -2.59%.
| Return on Equity (ROE) | -18.58% |
| Return on Assets (ROA) | -1.16% |
| Return on Invested Capital (ROIC) | -2.59% |
| Return on Capital Employed (ROCE) | -1.77% |
| Weighted Average Cost of Capital (WACC) | 10.30% |
| Revenue Per Employee | $1.69M |
| Profits Per Employee | -$92,857 |
| Employee Count | 35 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 1.62 |
Taxes
In the past 12 months, FENC has paid $148,000 in taxes.
| Income Tax | 148,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +22.37% in the last 52 weeks. The beta is 1.10, so FENC's price volatility has been similar to the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | +22.37% |
| 50-Day Moving Average | 11.08 |
| 200-Day Moving Average | 8.74 |
| Relative Strength Index (RSI) | 40.54 |
| Average Volume (20 Days) | 250,846 |
Short Selling Information
The latest short interest is 520,659, so 1.48% of the outstanding shares have been sold short.
| Short Interest | 520,659 |
| Short Previous Month | 532,095 |
| Short % of Shares Out | 1.48% |
| Short % of Float | 2.62% |
| Short Ratio (days to cover) | 2.12 |
Income Statement
In the last 12 months, FENC had revenue of $59.22 million and -$3.25 million in losses. Loss per share was -$0.10.
| Revenue | 59.22M |
| Gross Profit | 55.51M |
| Operating Income | -1.12M |
| Pretax Income | -3.10M |
| Net Income | -3.25M |
| EBITDA | -1.02M |
| EBIT | -1.12M |
| Loss Per Share | -$0.10 |
Balance Sheet
The company has $41.25 million in cash and no debt, with a net cash position of $41.25 million or $1.18 per share.
| Cash & Cash Equivalents | 41.25M |
| Total Debt | n/a |
| Net Cash | 41.25M |
| Net Cash Per Share | $1.18 |
| Equity (Book Value) | 42.44M |
| Book Value Per Share | 1.21 |
| Working Capital | 60.11M |
Cash Flow
| Operating Cash Flow | -2.04M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 102,667 |
| Net Borrowing | -19.48M |
| Free Cash Flow | -2.04M |
| FCF Per Share | -$0.06 |
Margins
Gross margin is 93.73%, with operating and profit margins of -1.90% and -5.49%.
| Gross Margin | 93.73% |
| Operating Margin | -1.90% |
| Pretax Margin | -5.24% |
| Profit Margin | -5.49% |
| EBITDA Margin | -1.72% |
| EBIT Margin | -1.90% |
| FCF Margin | n/a |
Dividends & Yields
FENC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.69% |
| Shareholder Yield | -16.69% |
| Earnings Yield | -0.86% |
| FCF Yield | -0.54% |
Analyst Forecast
The average price target for FENC is $17.67, which is 71.22% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.67 |
| Price Target Difference | 71.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 45.99% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 5, 2014. It was a reverse split with a ratio of 1:3.
| Last Split Date | Sep 5, 2014 |
| Split Type | Reverse |
| Split Ratio | 1:3 |
Scores
FENC has an Altman Z-Score of 2.16 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.16 |
| Piotroski F-Score | 4 |